Additionally, eEF2K expression has been linked to the induction of epithelial-mesenchymal transition (EMT), migration, invasion, and chemoresistance in various cancers, including pancreatic [37], lung [50], breast cancer [36], and glioma [86], further supporting its oncogenic role in solid tumors. Here, EEF2K is linked to cancer.